VISTAGEN THERAPEUTICS, INC. Partners' Capital Account, Private Placement of Units
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Partners' Capital Account, Private Placement of Units of $525.00 thousand for the 3-month period ending 2012-12-31, per its 10-Q filed 2013-02-14.
Discontinued
us-gaap:PartnersCapitalAccountPrivatePlacementOfUnits · last filed 2013-02-14
- VISTAGEN THERAPEUTICS, INC. partners' capital account, private placement of units for the quarter ending 2012-12-31 was $525.00K.
| Period end | Partners' Capital Account, Private Placement of Units 3 month |
|---|---|
| 2012-12-31 | $525.00K 10-Q · filed 2013-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |